Euroapi S.A.S.U. (0EAP)
LSE
Closed
Sep 28, 2026
Day's Range
0.738552 wk Range
0.7230Overview - 0EAP - Euroapi S.A.S.U.
Key Statistics
Valuation
Enterprise Value
618.96M
Price / Book
‪0.05‬
EV / EBITDA
‪6.76‬
Profitability
Gross Margin
‪13.95%‬
Profit Margin
‪3.13%‬
Operating Margin
‪1.38%‬
Return on Assets
‪0.48%‬
Return on Equity
‪2.69%‬
Ownership
Shares Outstanding
95.18M
Float
50.14M
Held by Insiders
‪41.64%‬
Held by Institutions
‪23.33%‬
Price stats
50-Day Avg
‪0.9567‬
200-Day Avg
‪1.45‬
Peers - 0EAP - Euroapi S.A.S.U.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0EAPLSEEuroapi S.A.S.U.-334.81%52-week change—P/E (Trailing)‪3.13%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB+30.35%52-week change44.11P/E (Trailing)‪15.54%‬Profit Margin
- 0LERLSETeva Pharmaceutical Industries Ltd. ADR+52.30%52-week change31.31P/E (Trailing)‪51.78%‬Profit Margin
- 0A5VLSEViatris Inc.+43.33%52-week change11.39P/E (Trailing)‪11.88%‬Profit Margin
- 0DOLLSEBiofrontera AG+27.22%52-week change0.04P/E (Trailing)‪-17.92%‬Profit Margin
- 0AAJLSEPolyPeptide Group AG+41.70%52-week change0.30P/E (Trailing)‪3.14%‬Profit Margin
- 0SANLSESandoz Group AG+29.63%52-week change—P/E (Trailing)‪5.53%‬Profit Margin
Profile Summary - 0EAP - Euroapi S.A.S.U.
About
Euroapi S.A.S.U. is a leading pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of active pharmaceutical ingredients (APIs) and intermediates for human and veterinary medicines. With approximately 200 products in its portfolio, it offers one of the largest selections in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
